Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Statement

15 Jul 2011 07:00

RNS Number : 4487K
Alumasc Group PLC
15 July 2011
 



 

For release 7am, 15 July 2011

 

THE ALUMASC GROUP PLC - TRADING UPDATE

 

The Alumasc Group plc (ALU:L), the premium building and engineering products company, is providing a trading update relating to the year ended 30 June 2011.

 

Group revenues are expected to be in line with previous expectations. However, margins in the Building Products division for the fourth quarter were significantly lower than expected as a result of rising input costs that could not be recovered fully from customers, against a background of continued weakness in the UK construction market. In particular, the group's Construction Products business experienced a 20% increase in steel costs towards the end of the financial year, with profitability further diluted by an increase in the proportion of lower margin export sales. Consequently, underlying group profit for the full year is expected to be ahead of last year, but below previous management expectations.

 

Net cash flow performance to the year end continued to be robust and remained ahead of expectations.

 

Alumasc Precision recovered strongly during the year, benefiting from international demand for aluminium components used mainly in off-highway diesel engines, and particularly those used in mining and construction vehicles being sold into emerging economies. In view of the strong resurgence at Alumasc Precision over the last eighteen months and the encouraging future prospects for this business, the impairment charge booked in 2009 is to be reversed. This will give a one-off, non-cash gain of £1.2 million in the financial year just ended. As a consequence, the group's statutory profit before tax is expected to exceed underlying profit, and be well ahead of the prior year statutory result.

 

This impairment charge reversal will increase the book value of plant and equipment and therefore give rise to a higher depreciation charge of £0.3 million per annum in the 2011/12 financial year and beyond.

 

There is early evidence that a greater number of large buildings are now beginning to be funded, which could benefit Levolux, in particular, in the group's 2012/13 financial year. This is broadly consistent with external construction industry forecasts as to the expected timing of a return to growth. In the meantime, export sales strategies are beginning to add incrementally to Alumasc's revenues, and there are numerous initiatives across the group to mitigate the impact of the specific current weakness in the UK commercial new build sector, diversify routes to market and introduce new and innovative products.

 

Alumasc Precision continues to grow, although it is anticipated that growth will be at a more sustainable rate whilst the business prepares for the next phase of the project won last October to supply components for larger engine transmission systems, expected to start late in 2012.

 

In view of the continued strong group order book at Alumasc Precision, and the factors outlined above, the Board expects Alumasc to continue to make steady progress in 2011/12.

 

The Board will review the group dividend ahead of the announcement of its full year results in September in the light of current trading and future prospects at that time.

 

The results for the year ended 30 June 2011 will be announced on Tuesday, 6th September 2011. A presentation to analysts will be made at 9.30am on that day, at the offices of Peel Hunt, 111 Old Broad Street, London EC2N 1PH.

 

Enquiries:

 

The Alumasc Group plc

Paul Hooper (Group Chief Executive) Tel: 01536 383821

Andrew Magson (Group Finance Director) Tel: 01536 383844

 

Bankside Consultants

Simon Bloomfield or James Irvine-Fortescue Tel: 0207 367 8861

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFADAISLIL
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.